Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients

British Medical Journal

Volumn 329, Issue 7456, 2004, Pages 15-19

  Pirmohamed, Munir ^a   James, Sally ^c   Meakin, Shaun ^b   Green, Chris ^b   Scott, Andrew K ^c   Walley, Thomas J ^a   Farrar, Keith ^c   Park, B Kevin ^a   Breckenridge, Alasdair M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b University Hospital   (United Kingdom)

^c WIRRAL UNIVERSITY TEACHING HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LITHIUM; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PREDNISOLONE;

ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; BRADYCARDIA; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CONFUSION; CONSTIPATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DUODENUM ULCER; ELECTROLYTE DISTURBANCE; FRAGILITY FRACTURE; GASTROINTESTINAL HEMORRHAGE; HEART BLOCK; HEMATOMA; HEMATURIA; HOSPITAL ADMISSION; HOSPITAL BED CAPACITY; HOSPITAL COST; HUMAN; HYPERGLYCEMIA; HYPONATREMIA; HYPOTENSION; KIDNEY FAILURE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; ULCER PERFORATION; URINE RETENTION; VOMITING; WHEEZING;

EID: 3042723720     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.329.7456.15     Document Type: Article

References (33)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients - a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
2. Kvasz M, Allen IE, Gordon MJ, Ro EY, Estok R, Olkin I, et al. Adverse drug reactions in hospitalized patients: a critique of a meta-analysis. MedGenMed 2000;2:E3.
3. Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Bandolier Extra 2002;June:1-16.
4. Ghose K. Hospital bed occupancy due to drug-related problems. J R Soc Med 1980;73:853-6.
5. Gosney M, Tallis R. Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet 1984;ii:564-7.
6. Hurwitz N. Admissions to hospital due to drugs. BMJ 1969;i:539-40.
7. Hurwitz N. Predisposing factors in adverse reactions to drugs. BMJ 1969;i:536-9.
8. Hurwitz N, Wade OL. Intensive hospital monitoring of adverse reactions to drugs. BMJ 1969;i:531-6.
9. Leach S, Roy SS. Adverse drug reactions: an investigation on an acute geriatric ward. Age Ageing 1986;15:241-6.
10. Williamson J, Chopin JM. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing 1980;9:73-80.
11. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992;21:294-300.
12. Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol. 1996;42:423-9.
13. Howard RL, Avery AJ, Howard PD, Partridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003;12:280-5.
14. Bhalla N, Duggan C, Dhillon S. The incidence and nature of drug-related admissions to hospital. Pharmaceutical J 2003;270:583-6.
15. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255-9.
16. British Medical Association, Royal Pharmaceutical Society of Great Britain. British national formulary. London: BMA, RPS, 2002 (No 44).
17. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberst EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
18. Jones JK. Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reporting. Fam Community Health 1982;5:58-67.
19. Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. In: Davies DM, ed. Textbook of adverse drug reactions. Oxford: Oxford University Press, 1991:18-45.
20. Hallas J, Harvald B, Gram LF, Grodum E, Prosen K, Haghfelt T, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990;228:83-90.
21. Chartered Institute of Public Finance and Accountancy (CIPFA). The health service financial database and comparative tool. Croydon: Institute of Public Finance, 2002.
22. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993;27:832-40.
23. Winterstein AG, Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital admissions. Ann Pharmacother 2002;36:1238-48.
24. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002;24:46-54.
25. Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995;310:827-30.
26. Rodriguez-Monguio R, Otero M, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics 2003;21:623-50.
27. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. JAMA 1997;277:307-11.
28. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-6.
29. Department of Health. Hospital episode statistics 2001-2. www.doh.gov.uk/hes/free_data/index.html (accessed 13 Nov 2003).
30. Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MG, et al. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med 2000;346:1800-6.
31. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000;56:181-6.
32. Langman MJ. Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden? Pharmacoepidemiol Drug Saf 2001;10:13-9.
33. Department of Health. Medicines for older people: implementing medicines-related aspects of the NSF for older people. London: Department of Health, 2001.